Altered microRNA expression and immunosuppressive cytokine production by regulatory t cells of ulcerative colitis patients

Immunological Investigations

Volumn 45, Issue 1, 2016, Pages 63-74

  Mohammadnia Afrouzi, Mousa ^a   Hosseini, Ahmad Zavaran ^a   Khalili, Ali ^b   Abediankenari, Saeid ^c   Amari, Afshin ^d   Aghili, Babak ^e   Nataj, Hadi Hossein ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

IL 10; IL 35; microRNA; regulatory T cells; ulcerative colitis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 35; INTERLEUKIN 7 RECEPTOR; MICRORNA; MICRORNA 146A; MICRORNA 155; MICRORNA 181A; MICRORNA 181C; MICRORNA 21; MICRORNA 29A; MICRORNA 29B; MICRORNA 31; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; MEMBRANE ANTIGEN;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE COURSE; DOWN REGULATION; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; RNA ANALYSIS; ULCERATIVE COLITIS; UPREGULATION; BIOSYNTHESIS; CASE CONTROL STUDY; CLUSTER ANALYSIS; COLITIS, ULCERATIVE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; MULTIGENE FAMILY; SEVERITY OF ILLNESS INDEX; T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT;

ADULT; ANTIGENS, SURFACE; BIOMARKERS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COLITIS, ULCERATIVE; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; MICRORNAS; MIDDLE AGED; MULTIGENE FAMILY; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84953775296     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2015.1103749     Document Type: Article

References (47)

1. Bacchetta R, Passerini L, Gambineri E., et al. (2006). Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest, 116 (6), 1713-22
2. Bartel DP. (2009). MicroRNAs: Target recognition and regulatory functions. Cell, 136 (2), 215-33
3. Bettini M, Vignali DA. (2009). Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol, 21 (6), 612-8
4. Carissimi C, Carucci N, Colombo T., et al. (2014). miR-21 is a negative modulator of T-cell activation. Biochimie, 107 (. Pt B), 319-26
5. Chen CZ, Li L, Lodish HF, Bartel DP. (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science, 303 (5654), 83-6
6. Chong MM, Rasmussen JP, Rudensky AY, Littman DR. (2008). The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med, 205 (9), 2005-17
7. Cobb BS, Hertweck A, Smith J., et al. (2006) A role for Dicer in immune regulation. J Exp Med, 203 (11), 2519-27
8. Collison LW, Chaturvedi V, Henderson AL., et al. (2010). IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol, 11 (12), 1093-101
9. Collison LW, Pillai MR, Chaturvedi V, Vignali DAA. (2009). Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-And IL-10-dependent manner. J Immunol, 182 (10), 6121-8
10. Collison LW, Workman CJ, Kuo TT., et al. (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450 (7169), 566-9
11. Devasthanam AS, Tomasi TB. (2014). Dicer in immune cell development and function. Immunol Invest, 43 (2), 182-95
12. Fontenot JD, Gavin MA, Rudensky AY. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol, 4 (4), 330-6
13. Gambineri E, Torgerson TR, Ochs HD. (2003). Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol, 15 (4), 430-5
14. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM. (2007). Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods, 319 (1-2), 41-52
15. Himmel ME, Yao Y, Orban PC., et al. (2012). Regulatory T-cell therapy for inflammatory bowel disease: More questions than answers. Immunology, 136 (2), 115-22
16. Huehn J, Polansky JK, Hamann A. (2009). Epigenetic control of FOXP3 expression: The key to a stable regulatory T-cell lineage? Nat Rev Immunol, 9 (2), 83-9
17. Iliopoulos D, Kavousanaki M, Ioannou M, et al. (2011). The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21. Eur J Immunol, 41 (6), 1754-63
18. Kaser A, Zeissig S, Blumberg RS. (2010). Inflammatory bowel disease. Annu Rev Immunol, 28, 573-621
19. Kullberg MC, Hay V, Cheever AW., et al. (2005). TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol, 35 (10), 2886-95
20. Lichtiger S, Present DH, Kornbluth A., et al. (1994). Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med, 330 (26), 1841-5
21. Lindqvist CA, Christiansson LH, Simonsson B., et al. (2010). T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies. Immunology, 131 (3), 371-6
22. Liston A, Lu LF, O'Carroll D., et al. (2008). Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med, 205 (9), 1993-2004
23. Liu W, Putnam AL, Xu-Yu Z., et al. (2006). CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med, 203 (7), 1701-11
24. Lu LF, Boldin MP, Chaudhry A., et al. (2010). Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell, 142 (6), 914-29
25. Lu LF, Thai TH, Calado DP., et al. (2009). Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity, 30 (1), 80-91
26. Min M, Peng L, Yang Y., et al. (2014). MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a. Inflamm Bowel Dis, 20 (4), 652-9
27. Mohammadnia-Afrouzi, M, Hosseini AZ, Khalili A., et al. (2015). Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients. Autoimmunity, 1-6. (early online)
28. Murai M, Turovskaya O, Kim G., et al. (2009). Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol, 10 (11), 1178-84
29. Pauley KM, Cha S, Chan EK. (2009). MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun, 32 (3-4), 189-94
30. Pedersen AE, Lauritsen JP. (2009). CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2. Scand J Immunol, 70 (1), 40-3
31. Ranatunga, DC, Ramakrishnan A, Uprety P., et al. (2012) A protective role for human IL-10-expressing CD4+ T cells in colitis. J Immunol, 189 (3), 1243-52
32. Rouas R, Fayyad-Kazan H, El Zein N., et al. (2009). Human natural Treg microRNA signature: Role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol, 39 (6), 1608-18
33. Rubtsov YP, Rasmussen JP, Chi EY, et al. (2008). Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity, 28 (4), 546-58
34. Sakaguchi S. (2004). Naturally arising CD4+ regulatory t cells for immunologic self-Tolerance and negative control of immune responses. Annu Rev Immunol, 22, 531-62
35. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. (2010). FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol, 10 (7), 490-500
36. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. (2008). Regulatory T cells and immune tolerance. Cell, 133 (5), 775-87
37. Schmittgen TD, Livak KJ. (2008). Analyzing real-Time PCR data by the comparative C(T) method. Nat Protoc, 3 (6), 1101-8
38. Sheedy FJ. (2015). Turning 21: Induction of miR-21 as a key switch in the inflammatory response. Front Immunol, 6, 19
39. Shevach EM. (2009). Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity, 30 (5), 636-45
40. Takagi T, Naito Y, Mizushima K, et al. (2010). Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol, 25(s1), S129-33
41. Wing K, Sakaguchi S. (2010). Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol, 11 (1), 7-13
42. Wirtz S, Billmeier U, McHedlidze T., et al. (2011). Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology, 141 (5), 1875-86
43. Xiao C, Rajewsky K. (2009). MicroRNA control in the immune system: Basic principles. Cell, 136 (1), 26-36
44. Xue F, Li H, Zhang J., et al. (2013). miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun, 14 (2), 127-31
45. Yao R, Ma YL, Liang W., et al. (2012). MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One, 7 (10), e46082
46. Zhou X, Jeker LT, Fife BT., et al. (2008). Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med, 205 (9), 1983-91
47. Ziegler SF. (2006). FOXP3: Of mice and men. Annu Rev Immunol, 24, 209-26